Last reviewed · How we verify
Antiretroviral therapy alone
Antiretroviral therapy alone is a Small molecule drug developed by Juan A. Arnaiz. It is currently FDA-approved. Also known as: stavudine, Lamivudine, Indinavir.
At a glance
| Generic name | Antiretroviral therapy alone |
|---|---|
| Also known as | stavudine, Lamivudine, Indinavir |
| Sponsor | Juan A. Arnaiz |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India (NA)
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
- The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY (NA)
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks (PHASE4)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- Getting to Zero Among HHI MSM in the American South (NA)
- Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
- Study of GS-3242 in Participants With HIV-1; Substudy-05 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antiretroviral therapy alone CI brief — competitive landscape report
- Antiretroviral therapy alone updates RSS · CI watch RSS
- Juan A. Arnaiz portfolio CI
Frequently asked questions about Antiretroviral therapy alone
What is Antiretroviral therapy alone?
Antiretroviral therapy alone is a Small molecule drug developed by Juan A. Arnaiz.
Who makes Antiretroviral therapy alone?
Antiretroviral therapy alone is developed and marketed by Juan A. Arnaiz (see full Juan A. Arnaiz pipeline at /company/juan-a-arnaiz).
Is Antiretroviral therapy alone also known as anything else?
Antiretroviral therapy alone is also known as stavudine, Lamivudine, Indinavir.
What development phase is Antiretroviral therapy alone in?
Antiretroviral therapy alone is FDA-approved (marketed).
Related
- Manufacturer: Juan A. Arnaiz — full pipeline
- Also known as: stavudine, Lamivudine, Indinavir
- Compare: Antiretroviral therapy alone vs similar drugs
- Pricing: Antiretroviral therapy alone cost, discount & access